v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Jul. 31, 2025
Jul. 31, 2024
Operating expenses:        
Research and development $ 22,575 $ 11,549 $ 62,758 $ 27,042
General and administrative 7,372 5,210 20,926 17,800
Total operating expenses 29,947 16,759 83,684 44,842
Loss from operations 29,947 16,759 83,684 44,842
Other expenses (income), net:        
Interest income (2,233) (3,380) (7,451) (7,389)
Interest expense 758 751 2,244 2,042
Loss on extinguishment of debt       366
Other expenses (income), net 280 47 448 20
Total other income, net (1,195) (2,582) (4,759) (4,961)
Net loss before income taxes 28,752 14,177 78,925 39,881
Provision for (recovery of) income taxes 239 (29) 497 (38)
Net loss 28,991 14,148 79,422 39,843
Other comprehensive loss (income):        
Unrealized loss (gain) on available-for-sale investments 240   (210)  
Total comprehensive loss $ 29,231 $ 14,148 $ 79,212 $ 39,843
Net loss per share of common shares, basic $ 0.57 $ 0.32 $ 1.56 $ 1.12
Net loss per share of common shares, diluted $ 0.57 $ 0.32 $ 1.56 $ 1.12
Weighted-average common shares outstanding, basic 51,097,711 44,168,986 51,031,618 35,564,767
Weighted-average common shares outstanding, diluted 51,097,711 44,168,986 51,031,618 35,564,767